#1 Clinical Trials Search in Europe

Deoxyribonucleic Acid

This article explores the use of deoxyribonucleic acid (DNA) in various clinical trials. DNA, the molecule that carries genetic instructions in all living organisms, is being utilized in innovative ways to develop new treatments for conditions ranging from growth disorders to cancer. We’ll look at how DNA-based therapies are being tested to improve patient outcomes in myelodysplastic syndromes, growth hormone deficiencies, and severe limb ischemia.

Table of Contents

What is DNA?

DNA, which stands for deoxyribonucleic acid, is the genetic material found in nearly all living organisms. It contains the instructions needed for an organism to develop, survive, and reproduce. In the context of medical treatments, DNA is being explored as a powerful tool to treat various diseases.[1]

Medical Uses of DNA-based Therapies

DNA-based therapies are being developed to treat a variety of medical conditions. These therapies use DNA in different forms to help the body fight diseases or correct genetic problems. Some of the main types of DNA-based therapies include:

  • Gene therapy: This involves introducing new genes into a person’s cells to help treat or prevent disease.
  • DNA vaccines: These use pieces of DNA to stimulate the immune system to fight specific diseases.
  • DNA methyltransferase inhibitors (DNMTi): These drugs work by affecting how DNA is used in cells, potentially helping to treat certain types of cancer.[3]

Conditions Treated with DNA-based Therapies

DNA-based therapies are being studied and used to treat various conditions, including:

  • Growth disorders: DNA-based treatments like somatropin (a synthetic growth hormone) are used to treat conditions such as growth hormone deficiency and short stature related to certain genetic conditions.[1]
  • Severe limb ischemia: This is a condition where blood flow to the limbs is severely reduced. DNA-based therapies are being studied to help grow new blood vessels and improve circulation.[2]
  • Myelodysplastic syndromes (MDS): These are a group of disorders where the bone marrow doesn’t produce enough healthy blood cells. DNA-based treatments are being investigated to help improve blood cell production.[3]

How DNA-based Therapies Work

DNA-based therapies work in different ways depending on the specific treatment:

  • Gene therapy: This approach introduces new genes into a person’s cells to replace faulty genes or add genes that can help fight disease. For example, in the treatment of severe limb ischemia, a gene therapy called Neovasculgen is being studied. It uses a piece of DNA that carries instructions for making a protein called VEGF, which helps grow new blood vessels.[2]
  • DNA methyltransferase inhibitors (DNMTi): These drugs work by changing how DNA is used in cells. In some diseases, like certain types of cancer, DNA can be “turned off” in ways that are harmful. DNMTi drugs help “turn on” important genes that may have been incorrectly shut down.[3]

How DNA-based Therapies are Administered

The way DNA-based therapies are given to patients can vary:

  • Injections: Some treatments, like the gene therapy for severe limb ischemia, are given as injections into the affected area. For example, Neovasculgen is injected into the muscles along the affected blood vessels.[2]
  • Oral medications: Some DNA-based treatments, like certain DNMTi drugs, can be taken by mouth as pills.[3]
  • Intravenous (IV) infusions: Some therapies are given directly into the bloodstream through an IV.[3]

Ongoing Research and Clinical Trials

Several clinical trials are currently underway to study DNA-based therapies:

  • A study called GENEVA is testing a gene therapy (Neovasculgen) for severe limb ischemia. This trial aims to see if the treatment can reduce the need for repeat procedures and prevent amputations.[2]
  • The GeNeSIS study is looking at the long-term effects of growth hormone treatment (somatropin) in children with various growth disorders.[1]
  • A trial is examining a combination of a drug called BMS-986253 with DNA methyltransferase inhibitors for treating myelodysplastic syndromes.[3]

Potential Benefits of DNA-based Therapies

DNA-based therapies have the potential to offer several benefits:

  • Targeted treatment: These therapies can be designed to address specific genetic issues or stimulate particular biological processes.
  • Long-lasting effects: Some gene therapies may provide long-term benefits from a single treatment or a short course of treatments.
  • Improved quality of life: For conditions like severe limb ischemia, these therapies could reduce pain, prevent amputations, and improve mobility.[2]
  • New options for hard-to-treat conditions: DNA-based therapies may offer hope for conditions that have limited treatment options, such as certain types of myelodysplastic syndromes.[3]

Possible Side Effects and Safety Considerations

As with any medical treatment, DNA-based therapies can have side effects and safety considerations:

  • Immune system reactions: The body might react to the introduced DNA or the viruses sometimes used to deliver gene therapies.
  • Unintended effects: Changing gene activity could potentially have unexpected effects on other bodily processes.
  • Long-term unknowns: As many of these therapies are new, the long-term effects are still being studied.

It’s important to note that clinical trials carefully monitor patients for any side effects or safety issues. Patients considering DNA-based therapies should discuss the potential risks and benefits with their healthcare provider.[3][1][2]

Trial Name Condition DNA-based Intervention Key Outcomes
GENEVA Severe Lower Limb Ischemia pCMV-VEGF165 plasmid Freedom from repeated interventions, freedom from high amputations
GeNeSIS Growth Hormone Deficiency, Short Stature Somatropin (recombinant DNA origin) Final height gain, safety assessment
BMS-986253 in MDS Myelodysplastic Syndromes DNA methyltransferase inhibitors (DNMTi) Overall response rate, safety, progression-free survival

FAQ

  • What is deoxyribonucleic acid (DNA) and how is it used in clinical trials? DNA is the molecule that carries genetic instructions in all living organisms. In clinical trials, DNA is being used in various ways, such as gene therapy, where specific genes are introduced to treat diseases, or as a basis for creating drugs that can influence genetic processes in the body.
  • What conditions are being targeted by DNA-based therapies in these clinical trials? The clinical trials mentioned are targeting conditions such as severe limb ischemia, growth hormone deficiency, short stature, and myelodysplastic syndromes (a group of blood disorders).
  • How is DNA being used in the treatment of severe limb ischemia? In the GENEVA trial, a DNA-based drug called pCMV-VEGF165 is being tested in combination with endovascular treatment. This drug contains a gene that promotes the growth of new blood vessels, potentially improving blood flow in patients with severe limb ischemia.
  • What is the role of DNA in the treatment of growth disorders? In the GeNeSIS study, a drug called somatropin, which is made using recombinant DNA technology, is being used to treat children with growth hormone deficiency and other growth disorders. This drug mimics the natural growth hormone in the body.
  • How are DNA methyltransferase inhibitors (DNMTi) being used in myelodysplastic syndromes? In a trial for myelodysplastic syndromes, DNA methyltransferase inhibitors (DNMTi) are being used in combination with other drugs. These inhibitors can affect how genes are expressed in cells, potentially helping to treat the blood disorder.

Ongoing Clinical Trials on Deoxyribonucleic Acid

  • Study on the Effectiveness of 2LEBV and 2LXFS for Reducing Fatigue in Patients with Epstein-Barr Virus Infection

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium

  • Study on the Effectiveness of 2LHERP in Reducing Recurrent Cold Sores in Patients with Frequent Outbreaks

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

Glossary

  • Deoxyribonucleic acid (DNA): The molecule that carries genetic instructions for the development, functioning, growth and reproduction of all known living organisms and many viruses.
  • Gene therapy: A technique that uses genes to treat or prevent disease. It involves introducing specific genes into a patient's cells to help fight a disease.
  • Recombinant DNA: DNA that has been formed artificially by combining constituents from different organisms.
  • Myelodysplastic syndromes (MDS): A group of disorders caused by poorly formed or dysfunctional blood cells.
  • Endovascular treatment: A minimally invasive procedure performed inside your blood vessels to treat vascular diseases.
  • VEGF (Vascular Endothelial Growth Factor): A signal protein that stimulates the formation of blood vessels.
  • Somatropin: A man-made growth hormone used to treat growth failure in children and adults.
  • DNA methyltransferase inhibitors (DNMTi): Drugs that block the activity of DNA methyltransferase, an enzyme involved in gene expression.
  • Plasmid: A small DNA molecule within a cell that is physically separated from chromosomal DNA and can replicate independently.
  • Interleukin-8 (IL-8): A protein produced by white blood cells that plays a role in the immune response and inflammation.

References

  1. https://clinicaltrials.gov/study/NCT01088412
  2. https://clinicaltrials.gov/study/NCT06473740
  3. https://clinicaltrials.gov/study/NCT05148234